ClinicalTrials.Veeva

Menu

National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis (RECUR Registry)

N

National Center for Cardiovascular Diseases

Status

Enrolling

Conditions

Arteritis
Coronary Artery Disease
In-Stent Stenosis (Restenosis) of Coronary Artery Stent

Treatments

Other: Treatment made by experienced clinicians

Study type

Observational

Funder types

Other

Identifiers

NCT05437965
2021-ZX50

Details and patient eligibility

About

This project aims to establish a clinical cohort and diagnostic assessment framework by conducting a national multicenter cohort registry study. Through the collection of patients' clinical characteristics, it will achieve the registration, management, follow-up, and analysis of patients with Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR).

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥ 18 years;
  2. Patients meeting the diagnostic criteria for Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR);
  3. Patients fully informed about the trial procedures who provide written informed consent.

Exclusion criteria

  1. Patients presenting with any of the following:

    • Other severe comorbidities (e.g., malignant tumors, heart failure) with a life expectancy <12 months;

      • Known autoimmune/rheumatic diseases including systemic lupus erythematosus, Takayasu arteritis, Behçet's disease, polyarteritis nodosa, Wegener granulomatosis (granulomatosis with polyangiitis), eosinophilic arteritis, giant cell arteritis, rheumatoid arthritis, or IgG4-related disease;

        • Variant angina (Prinzmetal's angina);

          • Coronary artery dissection;

            • Thrombophilia;

              • Stent underexpansion.
  2. Presence of psychiatric disorders;

  3. Known inability to complete expected study follow-up for any reason;

  4. Patients deemed ineligible for enrollment by the investigator.

Trial design

1,000 participants in 1 patient group

Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR)
Treatment:
Other: Treatment made by experienced clinicians

Trial contacts and locations

1

Loading...

Central trial contact

Hong Jian Wang, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems